nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Topoisomerase Inhibitors—Irinotecan—colon cancer	0.443	1	CiPCiCtD
Etoposide—lung cancer—colon cancer	0.197	1	CtDrD
Etoposide—PTGS2—colon cancer	0.0578	0.54	CbGaD
Etoposide—ABCB1—colon cancer	0.0492	0.46	CbGaD
Etoposide—ABCC10—Vincristine—colon cancer	0.0236	0.131	CbGbCtD
Etoposide—ABCC3—Fluorouracil—colon cancer	0.0163	0.0904	CbGbCtD
Etoposide—ABCC3—Vincristine—colon cancer	0.0148	0.0824	CbGbCtD
Etoposide—ABCC10—Methotrexate—colon cancer	0.0143	0.0793	CbGbCtD
Etoposide—UGT1A1—Irinotecan—colon cancer	0.0127	0.0704	CbGbCtD
Etoposide—ABCC1—Irinotecan—colon cancer	0.0104	0.0579	CbGbCtD
Etoposide—ABCC1—Vincristine—colon cancer	0.00909	0.0506	CbGbCtD
Etoposide—ABCC3—Methotrexate—colon cancer	0.00897	0.0499	CbGbCtD
Etoposide—ABCC2—Irinotecan—colon cancer	0.0077	0.0428	CbGbCtD
Etoposide—ABCG2—Irinotecan—colon cancer	0.00696	0.0387	CbGbCtD
Etoposide—ABCC2—Vincristine—colon cancer	0.00673	0.0374	CbGbCtD
Etoposide—ABCG2—Fluorouracil—colon cancer	0.00668	0.0372	CbGbCtD
Etoposide—ABCG2—Vincristine—colon cancer	0.00609	0.0338	CbGbCtD
Etoposide—ABCC1—Methotrexate—colon cancer	0.00551	0.0306	CbGbCtD
Etoposide—ABCC2—Methotrexate—colon cancer	0.00408	0.0227	CbGbCtD
Etoposide—CYP3A5—Irinotecan—colon cancer	0.00386	0.0215	CbGbCtD
Etoposide—ABCG2—Methotrexate—colon cancer	0.00368	0.0205	CbGbCtD
Etoposide—CYP2C8—Fluorouracil—colon cancer	0.00356	0.0198	CbGbCtD
Etoposide—CYP3A5—Vincristine—colon cancer	0.00337	0.0188	CbGbCtD
Etoposide—CYP1A2—Fluorouracil—colon cancer	0.00276	0.0153	CbGbCtD
Etoposide—ABCB1—Irinotecan—colon cancer	0.00251	0.014	CbGbCtD
Etoposide—ABCB1—Vincristine—colon cancer	0.00219	0.0122	CbGbCtD
Etoposide—CYP3A4—Irinotecan—colon cancer	0.0015	0.00836	CbGbCtD
Etoposide—ABCB1—Methotrexate—colon cancer	0.00133	0.00739	CbGbCtD
Etoposide—CYP3A4—Vincristine—colon cancer	0.00131	0.00731	CbGbCtD
Etoposide—ABCC2—bile—colon cancer	0.00128	0.0741	CbGeAlD
Etoposide—TOP2B—Topotecan—Irinotecan—colon cancer	0.00085	0.714	CbGdCrCtD
Etoposide—GSTT1—renal system—colon cancer	0.000461	0.0267	CbGeAlD
Etoposide—TOP2B—embryo—colon cancer	0.000449	0.0259	CbGeAlD
Etoposide—ABCC3—gall bladder—colon cancer	0.000445	0.0257	CbGeAlD
Etoposide—GSTP1—gall bladder—colon cancer	0.000443	0.0256	CbGeAlD
Etoposide—GSTT1—lymphoid tissue—colon cancer	0.000383	0.0221	CbGeAlD
Etoposide—GSTT1—digestive system—colon cancer	0.000378	0.0219	CbGeAlD
Etoposide—ABCC6—renal system—colon cancer	0.000374	0.0216	CbGeAlD
Etoposide—TOP2B—smooth muscle tissue—colon cancer	0.000353	0.0204	CbGeAlD
Etoposide—TOP2B—renal system—colon cancer	0.00034	0.0196	CbGeAlD
Etoposide—TOP2B—lymphoid tissue—colon cancer	0.000282	0.0163	CbGeAlD
Etoposide—GSTT1—liver—colon cancer	0.000282	0.0163	CbGeAlD
Etoposide—GSTP1—embryo—colon cancer	0.000281	0.0162	CbGeAlD
Etoposide—TOP2B—digestive system—colon cancer	0.000279	0.0161	CbGeAlD
Etoposide—UGT1A1—renal system—colon cancer	0.000271	0.0156	CbGeAlD
Etoposide—TOP2B—bone marrow—colon cancer	0.000257	0.0148	CbGeAlD
Etoposide—PTGS1—endothelium—colon cancer	0.000249	0.0144	CbGeAlD
Etoposide—TOP2B—vagina—colon cancer	0.000246	0.0142	CbGeAlD
Etoposide—PTGS2—endothelium—colon cancer	0.000238	0.0138	CbGeAlD
Etoposide—PTGS1—blood vessel—colon cancer	0.00023	0.0133	CbGeAlD
Etoposide—GSTP1—epithelium—colon cancer	0.000229	0.0133	CbGeAlD
Etoposide—ABCC6—liver—colon cancer	0.000229	0.0132	CbGeAlD
Etoposide—UGT1A1—digestive system—colon cancer	0.000222	0.0128	CbGeAlD
Etoposide—GSTP1—smooth muscle tissue—colon cancer	0.000221	0.0128	CbGeAlD
Etoposide—PTGS2—blood vessel—colon cancer	0.00022	0.0127	CbGeAlD
Etoposide—ABCC3—renal system—colon cancer	0.000214	0.0123	CbGeAlD
Etoposide—GSTP1—renal system—colon cancer	0.000213	0.0123	CbGeAlD
Etoposide—ABCC10—renal system—colon cancer	0.000213	0.0123	CbGeAlD
Etoposide—TOP2B—liver—colon cancer	0.000208	0.012	CbGeAlD
Etoposide—PTGS2—gall bladder—colon cancer	0.000207	0.012	CbGeAlD
Etoposide—TOP2A—bone marrow—colon cancer	0.000189	0.0109	CbGeAlD
Etoposide—TOP2A—vagina—colon cancer	0.000181	0.0105	CbGeAlD
Etoposide—GSTP1—lymphoid tissue—colon cancer	0.000177	0.0102	CbGeAlD
Etoposide—ABCC10—lymphoid tissue—colon cancer	0.000177	0.0102	CbGeAlD
Etoposide—ABCC3—digestive system—colon cancer	0.000175	0.0101	CbGeAlD
Etoposide—GSTP1—digestive system—colon cancer	0.000174	0.0101	CbGeAlD
Etoposide—ABCC10—digestive system—colon cancer	0.000174	0.0101	CbGeAlD
Etoposide—ABCC2—renal system—colon cancer	0.000171	0.00987	CbGeAlD
Etoposide—UGT1A1—liver—colon cancer	0.000165	0.00956	CbGeAlD
Etoposide—GSTP1—bone marrow—colon cancer	0.000161	0.0093	CbGeAlD
Etoposide—ABCC10—bone marrow—colon cancer	0.000161	0.00929	CbGeAlD
Etoposide—TOP2B—lymph node—colon cancer	0.000159	0.0092	CbGeAlD
Etoposide—GSTP1—vagina—colon cancer	0.000154	0.00891	CbGeAlD
Etoposide—ABCC10—vagina—colon cancer	0.000154	0.0089	CbGeAlD
Etoposide—ABCC2—digestive system—colon cancer	0.00014	0.00809	CbGeAlD
Etoposide—TOP2A—Topotecan—Irinotecan—colon cancer	0.000137	0.115	CbGdCrCtD
Etoposide—ABCB1—blood vessel—colon cancer	0.000136	0.00786	CbGeAlD
Etoposide—PTGS2—embryo—colon cancer	0.000131	0.00758	CbGeAlD
Etoposide—ABCC3—liver—colon cancer	0.000131	0.00755	CbGeAlD
Etoposide—GSTP1—liver—colon cancer	0.00013	0.00751	CbGeAlD
Etoposide—ABCC10—liver—colon cancer	0.00013	0.00751	CbGeAlD
Etoposide—CYP2C8—renal system—colon cancer	0.000128	0.0074	CbGeAlD
Etoposide—CYP1A2—renal system—colon cancer	0.00012	0.00693	CbGeAlD
Etoposide—TOP2A—lymph node—colon cancer	0.000117	0.00676	CbGeAlD
Etoposide—CYP3A5—renal system—colon cancer	0.000116	0.00668	CbGeAlD
Etoposide—PTGS1—epithelium—colon cancer	0.000112	0.00647	CbGeAlD
Etoposide—ABCC1—vagina—colon cancer	0.000109	0.0063	CbGeAlD
Etoposide—PTGS1—smooth muscle tissue—colon cancer	0.000108	0.00623	CbGeAlD
Etoposide—CYP2E1—renal system—colon cancer	0.000108	0.00623	CbGeAlD
Etoposide—PTGS2—epithelium—colon cancer	0.000107	0.00618	CbGeAlD
Etoposide—ABCC2—liver—colon cancer	0.000104	0.00603	CbGeAlD
Etoposide—PTGS1—renal system—colon cancer	0.000104	0.006	CbGeAlD
Etoposide—PTGS2—smooth muscle tissue—colon cancer	0.000103	0.00596	CbGeAlD
Etoposide—ABCC3—lymph node—colon cancer	0.0001	0.00579	CbGeAlD
Etoposide—GSTP1—lymph node—colon cancer	9.97e-05	0.00576	CbGeAlD
Etoposide—ABCC10—lymph node—colon cancer	9.96e-05	0.00576	CbGeAlD
Etoposide—PTGS2—renal system—colon cancer	9.92e-05	0.00574	CbGeAlD
Etoposide—CYP1A2—digestive system—colon cancer	9.83e-05	0.00568	CbGeAlD
Etoposide—TOP2A—Vindesine—Vincristine—colon cancer	9.82e-05	0.0825	CbGdCrCtD
Etoposide—CYP3A5—digestive system—colon cancer	9.48e-05	0.00548	CbGeAlD
Etoposide—ABCG2—bone marrow—colon cancer	9.41e-05	0.00544	CbGeAlD
Etoposide—CYP2C8—vagina—colon cancer	9.27e-05	0.00536	CbGeAlD
Etoposide—ABCC1—liver—colon cancer	9.19e-05	0.00531	CbGeAlD
Etoposide—ABCG2—vagina—colon cancer	9.02e-05	0.00521	CbGeAlD
Etoposide—CYP2E1—lymphoid tissue—colon cancer	8.95e-05	0.00517	CbGeAlD
Etoposide—CYP2E1—digestive system—colon cancer	8.84e-05	0.00511	CbGeAlD
Etoposide—CYP3A4—renal system—colon cancer	8.67e-05	0.00501	CbGeAlD
Etoposide—PTGS1—digestive system—colon cancer	8.52e-05	0.00492	CbGeAlD
Etoposide—CYP3A5—vagina—colon cancer	8.37e-05	0.00484	CbGeAlD
Etoposide—PTGS2—lymphoid tissue—colon cancer	8.24e-05	0.00476	CbGeAlD
Etoposide—PTGS2—digestive system—colon cancer	8.14e-05	0.00471	CbGeAlD
Etoposide—ABCB1—embryo—colon cancer	8.11e-05	0.00469	CbGeAlD
Etoposide—ABCC2—lymph node—colon cancer	8e-05	0.00462	CbGeAlD
Etoposide—CYP2C8—liver—colon cancer	7.82e-05	0.00452	CbGeAlD
Etoposide—ABCG2—liver—colon cancer	7.61e-05	0.0044	CbGeAlD
Etoposide—PTGS1—vagina—colon cancer	7.52e-05	0.00435	CbGeAlD
Etoposide—PTGS2—bone marrow—colon cancer	7.5e-05	0.00434	CbGeAlD
Etoposide—Flushing—Irinotecan—colon cancer	7.37e-05	0.00164	CcSEcCtD
Etoposide—Mediastinal disorder—Vincristine—colon cancer	7.35e-05	0.00164	CcSEcCtD
Etoposide—CYP1A2—liver—colon cancer	7.32e-05	0.00423	CbGeAlD
Etoposide—Cardiac arrest—Capecitabine—colon cancer	7.3e-05	0.00163	CcSEcCtD
Etoposide—Alopecia—Vincristine—colon cancer	7.2e-05	0.00161	CcSEcCtD
Etoposide—Angiopathy—Irinotecan—colon cancer	7.2e-05	0.00161	CcSEcCtD
Etoposide—PTGS2—vagina—colon cancer	7.19e-05	0.00416	CbGeAlD
Etoposide—Immune system disorder—Irinotecan—colon cancer	7.17e-05	0.0016	CcSEcCtD
Etoposide—Mediastinal disorder—Irinotecan—colon cancer	7.15e-05	0.0016	CcSEcCtD
Etoposide—Chills—Irinotecan—colon cancer	7.12e-05	0.00159	CcSEcCtD
Etoposide—Mouth ulceration—Methotrexate—colon cancer	7.12e-05	0.00159	CcSEcCtD
Etoposide—CYP3A4—digestive system—colon cancer	7.11e-05	0.00411	CbGeAlD
Etoposide—CYP3A5—liver—colon cancer	7.06e-05	0.00408	CbGeAlD
Etoposide—ABCC1—lymph node—colon cancer	7.04e-05	0.00407	CbGeAlD
Etoposide—Alopecia—Irinotecan—colon cancer	7.01e-05	0.00156	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Capecitabine—colon cancer	6.92e-05	0.00154	CcSEcCtD
Etoposide—Back pain—Vincristine—colon cancer	6.86e-05	0.00153	CcSEcCtD
Etoposide—Sepsis—Methotrexate—colon cancer	6.83e-05	0.00152	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Capecitabine—colon cancer	6.77e-05	0.00151	CcSEcCtD
Etoposide—Alopecia—Fluorouracil—colon cancer	6.72e-05	0.0015	CcSEcCtD
Etoposide—Back pain—Irinotecan—colon cancer	6.68e-05	0.00149	CcSEcCtD
Etoposide—Muscle spasms—Irinotecan—colon cancer	6.64e-05	0.00148	CcSEcCtD
Etoposide—Dysphagia—Capecitabine—colon cancer	6.64e-05	0.00148	CcSEcCtD
Etoposide—ABCB1—epithelium—colon cancer	6.62e-05	0.00383	CbGeAlD
Etoposide—CYP2E1—liver—colon cancer	6.59e-05	0.00381	CbGeAlD
Etoposide—Anaemia—Vincristine—colon cancer	6.56e-05	0.00146	CcSEcCtD
Etoposide—Bronchospasm—Capecitabine—colon cancer	6.53e-05	0.00146	CcSEcCtD
Etoposide—Sweating increased—Capecitabine—colon cancer	6.47e-05	0.00144	CcSEcCtD
Etoposide—Ill-defined disorder—Irinotecan—colon cancer	6.41e-05	0.00143	CcSEcCtD
Etoposide—Anaemia—Irinotecan—colon cancer	6.39e-05	0.00142	CcSEcCtD
Etoposide—Vertigo—Vincristine—colon cancer	6.37e-05	0.00142	CcSEcCtD
Etoposide—Leukopenia—Vincristine—colon cancer	6.35e-05	0.00142	CcSEcCtD
Etoposide—Pancytopenia—Capecitabine—colon cancer	6.3e-05	0.00141	CcSEcCtD
Etoposide—Malaise—Irinotecan—colon cancer	6.23e-05	0.00139	CcSEcCtD
Etoposide—Vertigo—Irinotecan—colon cancer	6.21e-05	0.00139	CcSEcCtD
Etoposide—Neutropenia—Capecitabine—colon cancer	6.21e-05	0.00138	CcSEcCtD
Etoposide—TOP2A—Vinorelbine—Vincristine—colon cancer	6.2e-05	0.0521	CbGdCrCtD
Etoposide—Leukopenia—Irinotecan—colon cancer	6.19e-05	0.00138	CcSEcCtD
Etoposide—Convulsion—Vincristine—colon cancer	6.15e-05	0.00137	CcSEcCtD
Etoposide—ABCB1—renal system—colon cancer	6.14e-05	0.00355	CbGeAlD
Etoposide—Hypertension—Vincristine—colon cancer	6.13e-05	0.00137	CcSEcCtD
Etoposide—Anaemia—Fluorouracil—colon cancer	6.12e-05	0.00136	CcSEcCtD
Etoposide—Loss of consciousness—Irinotecan—colon cancer	6.07e-05	0.00135	CcSEcCtD
Etoposide—PTGS2—liver—colon cancer	6.06e-05	0.00351	CbGeAlD
Etoposide—Cough—Irinotecan—colon cancer	6.03e-05	0.00135	CcSEcCtD
Etoposide—Hypertension—Irinotecan—colon cancer	5.97e-05	0.00133	CcSEcCtD
Etoposide—Pneumonia—Capecitabine—colon cancer	5.95e-05	0.00133	CcSEcCtD
Etoposide—Leukopenia—Fluorouracil—colon cancer	5.92e-05	0.00132	CcSEcCtD
Etoposide—Infestation—Capecitabine—colon cancer	5.92e-05	0.00132	CcSEcCtD
Etoposide—Infestation NOS—Capecitabine—colon cancer	5.92e-05	0.00132	CcSEcCtD
Etoposide—Anaphylactoid reaction—Methotrexate—colon cancer	5.91e-05	0.00132	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Capecitabine—colon cancer	5.87e-05	0.00131	CcSEcCtD
Etoposide—Acute coronary syndrome—Capecitabine—colon cancer	5.83e-05	0.0013	CcSEcCtD
Etoposide—ABCG2—lymph node—colon cancer	5.83e-05	0.00337	CbGeAlD
Etoposide—Renal failure—Capecitabine—colon cancer	5.82e-05	0.0013	CcSEcCtD
Etoposide—Discomfort—Irinotecan—colon cancer	5.81e-05	0.0013	CcSEcCtD
Etoposide—Neuropathy peripheral—Capecitabine—colon cancer	5.8e-05	0.00129	CcSEcCtD
Etoposide—Myocardial infarction—Capecitabine—colon cancer	5.8e-05	0.00129	CcSEcCtD
Etoposide—Anaphylactic shock—Vincristine—colon cancer	5.79e-05	0.00129	CcSEcCtD
Etoposide—Jaundice—Capecitabine—colon cancer	5.77e-05	0.00129	CcSEcCtD
Etoposide—Stomatitis—Capecitabine—colon cancer	5.77e-05	0.00129	CcSEcCtD
Etoposide—Infection—Vincristine—colon cancer	5.75e-05	0.00128	CcSEcCtD
Etoposide—Convulsion—Fluorouracil—colon cancer	5.73e-05	0.00128	CcSEcCtD
Etoposide—Confusional state—Irinotecan—colon cancer	5.69e-05	0.00127	CcSEcCtD
Etoposide—Thrombocytopenia—Vincristine—colon cancer	5.67e-05	0.00126	CcSEcCtD
Etoposide—Anaphylactic shock—Irinotecan—colon cancer	5.64e-05	0.00126	CcSEcCtD
Etoposide—Chest pain—Fluorouracil—colon cancer	5.63e-05	0.00126	CcSEcCtD
Etoposide—Infection—Irinotecan—colon cancer	5.6e-05	0.00125	CcSEcCtD
Etoposide—Hyperhidrosis—Vincristine—colon cancer	5.6e-05	0.00125	CcSEcCtD
Etoposide—Hepatobiliary disease—Capecitabine—colon cancer	5.6e-05	0.00125	CcSEcCtD
Etoposide—Discomfort—Fluorouracil—colon cancer	5.57e-05	0.00124	CcSEcCtD
Etoposide—Agranulocytosis—Capecitabine—colon cancer	5.52e-05	0.00123	CcSEcCtD
Etoposide—Thrombocytopenia—Irinotecan—colon cancer	5.52e-05	0.00123	CcSEcCtD
Etoposide—Anorexia—Vincristine—colon cancer	5.52e-05	0.00123	CcSEcCtD
Etoposide—Hyperhidrosis—Irinotecan—colon cancer	5.45e-05	0.00122	CcSEcCtD
Etoposide—Confusional state—Fluorouracil—colon cancer	5.45e-05	0.00122	CcSEcCtD
Etoposide—Hypotension—Vincristine—colon cancer	5.41e-05	0.00121	CcSEcCtD
Etoposide—Anaphylactic shock—Fluorouracil—colon cancer	5.4e-05	0.00121	CcSEcCtD
Etoposide—Anorexia—Irinotecan—colon cancer	5.38e-05	0.0012	CcSEcCtD
Etoposide—Infection—Fluorouracil—colon cancer	5.37e-05	0.0012	CcSEcCtD
Etoposide—CYP3A4—liver—colon cancer	5.3e-05	0.00306	CbGeAlD
Etoposide—Thrombocytopenia—Fluorouracil—colon cancer	5.29e-05	0.00118	CcSEcCtD
Etoposide—Hypoaesthesia—Capecitabine—colon cancer	5.29e-05	0.00118	CcSEcCtD
Etoposide—Tachycardia—Fluorouracil—colon cancer	5.27e-05	0.00118	CcSEcCtD
Etoposide—Hypotension—Irinotecan—colon cancer	5.27e-05	0.00118	CcSEcCtD
Etoposide—Urinary tract disorder—Capecitabine—colon cancer	5.25e-05	0.00117	CcSEcCtD
Etoposide—Urethral disorder—Capecitabine—colon cancer	5.21e-05	0.00116	CcSEcCtD
Etoposide—Paraesthesia—Vincristine—colon cancer	5.2e-05	0.00116	CcSEcCtD
Etoposide—Anorexia—Fluorouracil—colon cancer	5.15e-05	0.00115	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Methotrexate—colon cancer	5.15e-05	0.00115	CcSEcCtD
Etoposide—ABCB1—lymphoid tissue—colon cancer	5.1e-05	0.00295	CbGeAlD
Etoposide—Paraesthesia—Irinotecan—colon cancer	5.06e-05	0.00113	CcSEcCtD
Etoposide—Hypotension—Fluorouracil—colon cancer	5.05e-05	0.00113	CcSEcCtD
Etoposide—ABCB1—digestive system—colon cancer	5.03e-05	0.00291	CbGeAlD
Etoposide—Decreased appetite—Vincristine—colon cancer	5.03e-05	0.00112	CcSEcCtD
Etoposide—Dyspnoea—Irinotecan—colon cancer	5.03e-05	0.00112	CcSEcCtD
Etoposide—Erythema multiforme—Capecitabine—colon cancer	5.02e-05	0.00112	CcSEcCtD
Etoposide—Somnolence—Irinotecan—colon cancer	5.01e-05	0.00112	CcSEcCtD
Etoposide—Gastrointestinal disorder—Vincristine—colon cancer	5e-05	0.00112	CcSEcCtD
Etoposide—Fatigue—Vincristine—colon cancer	4.99e-05	0.00111	CcSEcCtD
Etoposide—Eye disorder—Capecitabine—colon cancer	4.96e-05	0.00111	CcSEcCtD
Etoposide—Pain—Vincristine—colon cancer	4.95e-05	0.0011	CcSEcCtD
Etoposide—Constipation—Vincristine—colon cancer	4.95e-05	0.0011	CcSEcCtD
Etoposide—Cardiac disorder—Capecitabine—colon cancer	4.93e-05	0.0011	CcSEcCtD
Etoposide—Flushing—Capecitabine—colon cancer	4.93e-05	0.0011	CcSEcCtD
Etoposide—Decreased appetite—Irinotecan—colon cancer	4.9e-05	0.00109	CcSEcCtD
Etoposide—Gastrointestinal disorder—Irinotecan—colon cancer	4.87e-05	0.00109	CcSEcCtD
Etoposide—PTGS1—lymph node—colon cancer	4.86e-05	0.00281	CbGeAlD
Etoposide—Fatigue—Irinotecan—colon cancer	4.86e-05	0.00108	CcSEcCtD
Etoposide—Paraesthesia—Fluorouracil—colon cancer	4.85e-05	0.00108	CcSEcCtD
Etoposide—Pain—Irinotecan—colon cancer	4.82e-05	0.00108	CcSEcCtD
Etoposide—Constipation—Irinotecan—colon cancer	4.82e-05	0.00108	CcSEcCtD
Etoposide—Angiopathy—Capecitabine—colon cancer	4.82e-05	0.00108	CcSEcCtD
Etoposide—Dyspnoea—Fluorouracil—colon cancer	4.82e-05	0.00107	CcSEcCtD
Etoposide—Somnolence—Fluorouracil—colon cancer	4.8e-05	0.00107	CcSEcCtD
Etoposide—Immune system disorder—Capecitabine—colon cancer	4.8e-05	0.00107	CcSEcCtD
Etoposide—Mediastinal disorder—Capecitabine—colon cancer	4.79e-05	0.00107	CcSEcCtD
Etoposide—Chills—Capecitabine—colon cancer	4.77e-05	0.00106	CcSEcCtD
Etoposide—Gastrointestinal pain—Vincristine—colon cancer	4.74e-05	0.00106	CcSEcCtD
Etoposide—Decreased appetite—Fluorouracil—colon cancer	4.7e-05	0.00105	CcSEcCtD
Etoposide—Alopecia—Capecitabine—colon cancer	4.69e-05	0.00105	CcSEcCtD
Etoposide—Pancytopenia—Methotrexate—colon cancer	4.69e-05	0.00105	CcSEcCtD
Etoposide—Gastrointestinal disorder—Fluorouracil—colon cancer	4.66e-05	0.00104	CcSEcCtD
Etoposide—PTGS2—lymph node—colon cancer	4.65e-05	0.00269	CbGeAlD
Etoposide—Feeling abnormal—Irinotecan—colon cancer	4.65e-05	0.00104	CcSEcCtD
Etoposide—ABCB1—bone marrow—colon cancer	4.64e-05	0.00268	CbGeAlD
Etoposide—Neutropenia—Methotrexate—colon cancer	4.62e-05	0.00103	CcSEcCtD
Etoposide—Pain—Fluorouracil—colon cancer	4.62e-05	0.00103	CcSEcCtD
Etoposide—Gastrointestinal pain—Irinotecan—colon cancer	4.61e-05	0.00103	CcSEcCtD
Etoposide—Abdominal pain—Vincristine—colon cancer	4.58e-05	0.00102	CcSEcCtD
Etoposide—Body temperature increased—Vincristine—colon cancer	4.58e-05	0.00102	CcSEcCtD
Etoposide—Dysgeusia—Capecitabine—colon cancer	4.53e-05	0.00101	CcSEcCtD
Etoposide—Back pain—Capecitabine—colon cancer	4.47e-05	0.000998	CcSEcCtD
Etoposide—Body temperature increased—Irinotecan—colon cancer	4.46e-05	0.000995	CcSEcCtD
Etoposide—Abdominal pain—Irinotecan—colon cancer	4.46e-05	0.000995	CcSEcCtD
Etoposide—Feeling abnormal—Fluorouracil—colon cancer	4.45e-05	0.000993	CcSEcCtD
Etoposide—Muscle spasms—Capecitabine—colon cancer	4.45e-05	0.000992	CcSEcCtD
Etoposide—ABCB1—vagina—colon cancer	4.45e-05	0.00257	CbGeAlD
Etoposide—Pneumonia—Methotrexate—colon cancer	4.43e-05	0.000989	CcSEcCtD
Etoposide—Infestation NOS—Methotrexate—colon cancer	4.41e-05	0.000983	CcSEcCtD
Etoposide—Infestation—Methotrexate—colon cancer	4.41e-05	0.000983	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Methotrexate—colon cancer	4.37e-05	0.000974	CcSEcCtD
Etoposide—Renal failure—Methotrexate—colon cancer	4.33e-05	0.000966	CcSEcCtD
Etoposide—Stomatitis—Methotrexate—colon cancer	4.29e-05	0.000958	CcSEcCtD
Etoposide—Ill-defined disorder—Capecitabine—colon cancer	4.29e-05	0.000957	CcSEcCtD
Etoposide—Urticaria—Fluorouracil—colon cancer	4.29e-05	0.000957	CcSEcCtD
Etoposide—Anaemia—Capecitabine—colon cancer	4.27e-05	0.000954	CcSEcCtD
Etoposide—Body temperature increased—Fluorouracil—colon cancer	4.27e-05	0.000953	CcSEcCtD
Etoposide—Hypersensitivity—Vincristine—colon cancer	4.27e-05	0.000952	CcSEcCtD
Etoposide—TOP2A—Vinblastine—Vincristine—colon cancer	4.26e-05	0.0358	CbGdCrCtD
Etoposide—Malaise—Capecitabine—colon cancer	4.17e-05	0.00093	CcSEcCtD
Etoposide—Hepatobiliary disease—Methotrexate—colon cancer	4.17e-05	0.00093	CcSEcCtD
Etoposide—Vertigo—Capecitabine—colon cancer	4.16e-05	0.000927	CcSEcCtD
Etoposide—Hypersensitivity—Irinotecan—colon cancer	4.15e-05	0.000927	CcSEcCtD
Etoposide—Asthenia—Vincristine—colon cancer	4.15e-05	0.000927	CcSEcCtD
Etoposide—Leukopenia—Capecitabine—colon cancer	4.14e-05	0.000924	CcSEcCtD
Etoposide—Agranulocytosis—Methotrexate—colon cancer	4.11e-05	0.000917	CcSEcCtD
Etoposide—Loss of consciousness—Capecitabine—colon cancer	4.06e-05	0.000907	CcSEcCtD
Etoposide—Asthenia—Irinotecan—colon cancer	4.05e-05	0.000903	CcSEcCtD
Etoposide—Cough—Capecitabine—colon cancer	4.04e-05	0.0009	CcSEcCtD
Etoposide—Hypertension—Capecitabine—colon cancer	3.99e-05	0.000891	CcSEcCtD
Etoposide—Hypersensitivity—Fluorouracil—colon cancer	3.98e-05	0.000888	CcSEcCtD
Etoposide—Diarrhoea—Vincristine—colon cancer	3.96e-05	0.000884	CcSEcCtD
Etoposide—Chest pain—Capecitabine—colon cancer	3.94e-05	0.000878	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	3.91e-05	0.000872	CcSEcCtD
Etoposide—Urinary tract disorder—Methotrexate—colon cancer	3.91e-05	0.000871	CcSEcCtD
Etoposide—Discomfort—Capecitabine—colon cancer	3.89e-05	0.000868	CcSEcCtD
Etoposide—Urethral disorder—Methotrexate—colon cancer	3.88e-05	0.000865	CcSEcCtD
Etoposide—Diarrhoea—Irinotecan—colon cancer	3.86e-05	0.000861	CcSEcCtD
Etoposide—Dizziness—Vincristine—colon cancer	3.83e-05	0.000854	CcSEcCtD
Etoposide—Pruritus—Fluorouracil—colon cancer	3.82e-05	0.000853	CcSEcCtD
Etoposide—Confusional state—Capecitabine—colon cancer	3.81e-05	0.000849	CcSEcCtD
Etoposide—ABCB1—liver—colon cancer	3.75e-05	0.00217	CbGeAlD
Etoposide—Infection—Capecitabine—colon cancer	3.75e-05	0.000837	CcSEcCtD
Etoposide—Erythema multiforme—Methotrexate—colon cancer	3.74e-05	0.000834	CcSEcCtD
Etoposide—Dizziness—Irinotecan—colon cancer	3.73e-05	0.000832	CcSEcCtD
Etoposide—Eye disorder—Methotrexate—colon cancer	3.7e-05	0.000825	CcSEcCtD
Etoposide—Diarrhoea—Fluorouracil—colon cancer	3.7e-05	0.000824	CcSEcCtD
Etoposide—Thrombocytopenia—Capecitabine—colon cancer	3.7e-05	0.000824	CcSEcCtD
Etoposide—Tachycardia—Capecitabine—colon cancer	3.68e-05	0.000822	CcSEcCtD
Etoposide—Vomiting—Vincristine—colon cancer	3.68e-05	0.000821	CcSEcCtD
Etoposide—Cardiac disorder—Methotrexate—colon cancer	3.67e-05	0.000819	CcSEcCtD
Etoposide—Skin disorder—Capecitabine—colon cancer	3.67e-05	0.000818	CcSEcCtD
Etoposide—Rash—Vincristine—colon cancer	3.65e-05	0.000815	CcSEcCtD
Etoposide—Hyperhidrosis—Capecitabine—colon cancer	3.65e-05	0.000814	CcSEcCtD
Etoposide—Dermatitis—Vincristine—colon cancer	3.65e-05	0.000814	CcSEcCtD
Etoposide—Headache—Vincristine—colon cancer	3.63e-05	0.000809	CcSEcCtD
Etoposide—Anorexia—Capecitabine—colon cancer	3.6e-05	0.000803	CcSEcCtD
Etoposide—Angiopathy—Methotrexate—colon cancer	3.59e-05	0.000801	CcSEcCtD
Etoposide—Vomiting—Irinotecan—colon cancer	3.59e-05	0.0008	CcSEcCtD
Etoposide—Immune system disorder—Methotrexate—colon cancer	3.57e-05	0.000797	CcSEcCtD
Etoposide—Dizziness—Fluorouracil—colon cancer	3.57e-05	0.000797	CcSEcCtD
Etoposide—Mediastinal disorder—Methotrexate—colon cancer	3.56e-05	0.000795	CcSEcCtD
Etoposide—Rash—Irinotecan—colon cancer	3.56e-05	0.000793	CcSEcCtD
Etoposide—Dermatitis—Irinotecan—colon cancer	3.55e-05	0.000793	CcSEcCtD
Etoposide—Chills—Methotrexate—colon cancer	3.55e-05	0.000792	CcSEcCtD
Etoposide—Headache—Irinotecan—colon cancer	3.53e-05	0.000788	CcSEcCtD
Etoposide—Hypotension—Capecitabine—colon cancer	3.53e-05	0.000787	CcSEcCtD
Etoposide—Alopecia—Methotrexate—colon cancer	3.49e-05	0.00078	CcSEcCtD
Etoposide—Nausea—Vincristine—colon cancer	3.44e-05	0.000767	CcSEcCtD
Etoposide—Vomiting—Fluorouracil—colon cancer	3.43e-05	0.000766	CcSEcCtD
Etoposide—Rash—Fluorouracil—colon cancer	3.41e-05	0.00076	CcSEcCtD
Etoposide—Dermatitis—Fluorouracil—colon cancer	3.4e-05	0.000759	CcSEcCtD
Etoposide—Paraesthesia—Capecitabine—colon cancer	3.39e-05	0.000756	CcSEcCtD
Etoposide—Headache—Fluorouracil—colon cancer	3.38e-05	0.000755	CcSEcCtD
Etoposide—Dysgeusia—Methotrexate—colon cancer	3.37e-05	0.000752	CcSEcCtD
Etoposide—Dyspnoea—Capecitabine—colon cancer	3.36e-05	0.000751	CcSEcCtD
Etoposide—Nausea—Irinotecan—colon cancer	3.35e-05	0.000747	CcSEcCtD
Etoposide—Back pain—Methotrexate—colon cancer	3.33e-05	0.000743	CcSEcCtD
Etoposide—Decreased appetite—Capecitabine—colon cancer	3.28e-05	0.000732	CcSEcCtD
Etoposide—Gastrointestinal disorder—Capecitabine—colon cancer	3.26e-05	0.000727	CcSEcCtD
Etoposide—Fatigue—Capecitabine—colon cancer	3.25e-05	0.000726	CcSEcCtD
Etoposide—Constipation—Capecitabine—colon cancer	3.23e-05	0.00072	CcSEcCtD
Etoposide—Pain—Capecitabine—colon cancer	3.23e-05	0.00072	CcSEcCtD
Etoposide—Nausea—Fluorouracil—colon cancer	3.21e-05	0.000716	CcSEcCtD
Etoposide—Ill-defined disorder—Methotrexate—colon cancer	3.19e-05	0.000713	CcSEcCtD
Etoposide—Anaemia—Methotrexate—colon cancer	3.18e-05	0.00071	CcSEcCtD
Etoposide—Feeling abnormal—Capecitabine—colon cancer	3.11e-05	0.000694	CcSEcCtD
Etoposide—Malaise—Methotrexate—colon cancer	3.1e-05	0.000693	CcSEcCtD
Etoposide—Vertigo—Methotrexate—colon cancer	3.09e-05	0.00069	CcSEcCtD
Etoposide—Gastrointestinal pain—Capecitabine—colon cancer	3.09e-05	0.000689	CcSEcCtD
Etoposide—Leukopenia—Methotrexate—colon cancer	3.08e-05	0.000688	CcSEcCtD
Etoposide—Cough—Methotrexate—colon cancer	3e-05	0.00067	CcSEcCtD
Etoposide—Urticaria—Capecitabine—colon cancer	3e-05	0.000669	CcSEcCtD
Etoposide—Body temperature increased—Capecitabine—colon cancer	2.98e-05	0.000666	CcSEcCtD
Etoposide—Abdominal pain—Capecitabine—colon cancer	2.98e-05	0.000666	CcSEcCtD
Etoposide—Convulsion—Methotrexate—colon cancer	2.98e-05	0.000665	CcSEcCtD
Etoposide—Chest pain—Methotrexate—colon cancer	2.93e-05	0.000654	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	2.91e-05	0.000649	CcSEcCtD
Etoposide—Discomfort—Methotrexate—colon cancer	2.9e-05	0.000646	CcSEcCtD
Etoposide—ABCB1—lymph node—colon cancer	2.88e-05	0.00166	CbGeAlD
Etoposide—Confusional state—Methotrexate—colon cancer	2.83e-05	0.000632	CcSEcCtD
Etoposide—Anaphylactic shock—Methotrexate—colon cancer	2.81e-05	0.000627	CcSEcCtD
Etoposide—Infection—Methotrexate—colon cancer	2.79e-05	0.000623	CcSEcCtD
Etoposide—Hypersensitivity—Capecitabine—colon cancer	2.78e-05	0.00062	CcSEcCtD
Etoposide—Thrombocytopenia—Methotrexate—colon cancer	2.75e-05	0.000614	CcSEcCtD
Etoposide—Skin disorder—Methotrexate—colon cancer	2.73e-05	0.000609	CcSEcCtD
Etoposide—Hyperhidrosis—Methotrexate—colon cancer	2.72e-05	0.000606	CcSEcCtD
Etoposide—Asthenia—Capecitabine—colon cancer	2.71e-05	0.000604	CcSEcCtD
Etoposide—Anorexia—Methotrexate—colon cancer	2.68e-05	0.000598	CcSEcCtD
Etoposide—Pruritus—Capecitabine—colon cancer	2.67e-05	0.000596	CcSEcCtD
Etoposide—Hypotension—Methotrexate—colon cancer	2.63e-05	0.000586	CcSEcCtD
Etoposide—Diarrhoea—Capecitabine—colon cancer	2.58e-05	0.000576	CcSEcCtD
Etoposide—Paraesthesia—Methotrexate—colon cancer	2.52e-05	0.000563	CcSEcCtD
Etoposide—Dyspnoea—Methotrexate—colon cancer	2.5e-05	0.000559	CcSEcCtD
Etoposide—Somnolence—Methotrexate—colon cancer	2.5e-05	0.000557	CcSEcCtD
Etoposide—Dizziness—Capecitabine—colon cancer	2.5e-05	0.000557	CcSEcCtD
Etoposide—Decreased appetite—Methotrexate—colon cancer	2.44e-05	0.000545	CcSEcCtD
Etoposide—Gastrointestinal disorder—Methotrexate—colon cancer	2.43e-05	0.000541	CcSEcCtD
Etoposide—Fatigue—Methotrexate—colon cancer	2.42e-05	0.00054	CcSEcCtD
Etoposide—Pain—Methotrexate—colon cancer	2.4e-05	0.000536	CcSEcCtD
Etoposide—Vomiting—Capecitabine—colon cancer	2.4e-05	0.000535	CcSEcCtD
Etoposide—Rash—Capecitabine—colon cancer	2.38e-05	0.000531	CcSEcCtD
Etoposide—Dermatitis—Capecitabine—colon cancer	2.38e-05	0.00053	CcSEcCtD
Etoposide—Headache—Capecitabine—colon cancer	2.36e-05	0.000528	CcSEcCtD
Etoposide—Feeling abnormal—Methotrexate—colon cancer	2.32e-05	0.000517	CcSEcCtD
Etoposide—Gastrointestinal pain—Methotrexate—colon cancer	2.3e-05	0.000513	CcSEcCtD
Etoposide—Nausea—Capecitabine—colon cancer	2.24e-05	0.0005	CcSEcCtD
Etoposide—Urticaria—Methotrexate—colon cancer	2.23e-05	0.000498	CcSEcCtD
Etoposide—Abdominal pain—Methotrexate—colon cancer	2.22e-05	0.000496	CcSEcCtD
Etoposide—Body temperature increased—Methotrexate—colon cancer	2.22e-05	0.000496	CcSEcCtD
Etoposide—Hypersensitivity—Methotrexate—colon cancer	2.07e-05	0.000462	CcSEcCtD
Etoposide—Asthenia—Methotrexate—colon cancer	2.02e-05	0.00045	CcSEcCtD
Etoposide—Pruritus—Methotrexate—colon cancer	1.99e-05	0.000444	CcSEcCtD
Etoposide—Diarrhoea—Methotrexate—colon cancer	1.92e-05	0.000429	CcSEcCtD
Etoposide—Dizziness—Methotrexate—colon cancer	1.86e-05	0.000415	CcSEcCtD
Etoposide—Vomiting—Methotrexate—colon cancer	1.79e-05	0.000399	CcSEcCtD
Etoposide—Rash—Methotrexate—colon cancer	1.77e-05	0.000395	CcSEcCtD
Etoposide—Dermatitis—Methotrexate—colon cancer	1.77e-05	0.000395	CcSEcCtD
Etoposide—Headache—Methotrexate—colon cancer	1.76e-05	0.000393	CcSEcCtD
Etoposide—Nausea—Methotrexate—colon cancer	1.67e-05	0.000372	CcSEcCtD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.09e-05	0.00105	CbGpPWpGaD
Etoposide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	1.09e-05	0.00105	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CA7—colon cancer	1.07e-05	0.00103	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—NRAS—colon cancer	1.07e-05	0.00103	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	1.05e-05	0.00101	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	1.05e-05	0.00101	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.03e-05	0.00099	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	1.02e-05	0.000981	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	1.02e-05	0.000981	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—TP53—colon cancer	1.01e-05	0.000971	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—MYC—colon cancer	9.95e-06	0.00096	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	9.91e-06	0.000956	CbGpPWpGaD
Etoposide—UGT1A1—NRF2 pathway—TGFB1—colon cancer	9.85e-06	0.000951	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—ABCB1—colon cancer	9.82e-06	0.000947	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	9.81e-06	0.000947	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	9.78e-06	0.000944	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—CASP3—colon cancer	9.71e-06	0.000937	CbGpPWpGaD
Etoposide—ABCC2—NRF2 pathway—TGFB1—colon cancer	9.61e-06	0.000928	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—CASP3—colon cancer	9.49e-06	0.000915	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—CCND1—colon cancer	9.45e-06	0.000912	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PPARG—colon cancer	9.45e-06	0.000912	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	9.42e-06	0.000909	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—APC—colon cancer	9.37e-06	0.000904	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	9.3e-06	0.000897	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—KRAS—colon cancer	9.19e-06	0.000887	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ODC1—colon cancer	9.15e-06	0.000883	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CHST5—colon cancer	9.15e-06	0.000883	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	9.12e-06	0.00088	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	9.11e-06	0.000879	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	9.09e-06	0.000877	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	9.05e-06	0.000873	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	8.91e-06	0.00086	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	8.91e-06	0.00086	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—TP53—colon cancer	8.75e-06	0.000844	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	8.72e-06	0.000841	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CHST5—colon cancer	8.61e-06	0.000831	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ODC1—colon cancer	8.61e-06	0.000831	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ODC1—colon cancer	8.59e-06	0.000829	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CHST5—colon cancer	8.59e-06	0.000829	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CA7—colon cancer	8.54e-06	0.000824	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	8.42e-06	0.000813	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—VEGFA—colon cancer	8.05e-06	0.000777	CbGpPWpGaD
Etoposide—PTGS2—Disease—AXIN2—colon cancer	7.85e-06	0.000757	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—HRAS—colon cancer	7.81e-06	0.000754	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	7.78e-06	0.000751	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	7.7e-06	0.000743	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—ABCB1—colon cancer	7.69e-06	0.000742	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—MYC—colon cancer	7.58e-06	0.000731	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TGFB1—colon cancer	7.56e-06	0.00073	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ODC1—colon cancer	7.44e-06	0.000718	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CHST5—colon cancer	7.44e-06	0.000718	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—ABCB1—colon cancer	7.44e-06	0.000718	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PTGS2—colon cancer	7.43e-06	0.000717	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—EGFR—colon cancer	7.41e-06	0.000715	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—TGFB1—colon cancer	7.39e-06	0.000713	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—TYMS—colon cancer	7.31e-06	0.000705	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.18e-06	0.000693	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	7.16e-06	0.000691	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	6.77e-06	0.000653	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CCND1—colon cancer	6.7e-06	0.000646	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	6.64e-06	0.000641	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	6.6e-06	0.000637	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CA7—colon cancer	6.59e-06	0.000636	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ODC1—colon cancer	6.48e-06	0.000626	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CHST5—colon cancer	6.48e-06	0.000626	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CDKN1A—colon cancer	6.48e-06	0.000625	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	6.43e-06	0.00062	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	6.37e-06	0.000614	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TP53—colon cancer	6.22e-06	0.000601	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	6.22e-06	0.0006	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—EP300—colon cancer	6.18e-06	0.000596	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—EP300—colon cancer	6.17e-06	0.000595	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CCND1—colon cancer	5.99e-06	0.000578	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	5.93e-06	0.000572	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	5.92e-06	0.000571	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CDKN1A—colon cancer	5.79e-06	0.000559	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	5.75e-06	0.000555	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.65e-06	0.000545	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.63e-06	0.000543	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	5.6e-06	0.000541	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—EP300—colon cancer	5.51e-06	0.000532	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—MYC—colon cancer	5.37e-06	0.000519	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PPARG—colon cancer	5.18e-06	0.0005	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CHST5—colon cancer	5.18e-06	0.0005	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ODC1—colon cancer	5.18e-06	0.0005	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	5.16e-06	0.000498	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	5.14e-06	0.000496	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	5.04e-06	0.000487	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	5.04e-06	0.000487	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—MYC—colon cancer	4.8e-06	0.000464	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	4.76e-06	0.00046	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.76e-06	0.000459	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.7e-06	0.000453	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	4.68e-06	0.000452	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—ABCB1—colon cancer	4.6e-06	0.000444	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PIK3CA—colon cancer	4.57e-06	0.000441	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	4.56e-06	0.00044	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—TYMS—colon cancer	4.51e-06	0.000436	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	4.51e-06	0.000435	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.43e-06	0.000427	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	4.41e-06	0.000425	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	4.38e-06	0.000422	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	4.23e-06	0.000409	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	4.19e-06	0.000405	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	4.08e-06	0.000394	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PTGS2—colon cancer	4.07e-06	0.000393	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CHST5—colon cancer	4e-06	0.000386	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ODC1—colon cancer	4e-06	0.000386	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	3.97e-06	0.000383	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TP53—colon cancer	3.95e-06	0.000381	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.78e-06	0.000364	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.74e-06	0.000361	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ABCB1—colon cancer	3.74e-06	0.00036	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—AKT1—colon cancer	3.74e-06	0.00036	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.68e-06	0.000355	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—TYMS—colon cancer	3.67e-06	0.000354	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	3.66e-06	0.000353	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	3.65e-06	0.000352	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ABCB1—colon cancer	3.6e-06	0.000348	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3.58e-06	0.000345	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	3.57e-06	0.000345	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—TYMS—colon cancer	3.54e-06	0.000341	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.48e-06	0.000335	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—EP300—colon cancer	3.39e-06	0.000327	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	3.38e-06	0.000326	CbGpPWpGaD
Etoposide—ABCC1—Disease—FGFR3—colon cancer	3.38e-06	0.000326	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PPARG—colon cancer	3.2e-06	0.000309	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ABCB1—colon cancer	3.17e-06	0.000306	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—TYMS—colon cancer	3.11e-06	0.0003	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.11e-06	0.0003	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	3.1e-06	0.000299	CbGpPWpGaD
Etoposide—ABCC1—Disease—APC—colon cancer	3.1e-06	0.000299	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.07e-06	0.000297	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ABCB1—colon cancer	3.05e-06	0.000294	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	3e-06	0.00029	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—TYMS—colon cancer	2.99e-06	0.000289	CbGpPWpGaD
Etoposide—ABCC1—Disease—BRAF—colon cancer	2.91e-06	0.000281	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.72e-06	0.000263	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PPARG—colon cancer	2.6e-06	0.000251	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	2.53e-06	0.000245	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTGS2—colon cancer	2.52e-06	0.000243	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PPARG—colon cancer	2.51e-06	0.000242	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PIK3CA—colon cancer	2.51e-06	0.000242	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.47e-06	0.000238	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ABCB1—colon cancer	2.42e-06	0.000233	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.42e-06	0.000233	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—TYMS—colon cancer	2.37e-06	0.000229	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTGS2—colon cancer	2.35e-06	0.000227	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.3e-06	0.000222	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ABCB1—colon cancer	2.28e-06	0.00022	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ABCB1—colon cancer	2.27e-06	0.000219	CbGpPWpGaD
Etoposide—PTGS2—Disease—FGFR3—colon cancer	2.27e-06	0.000219	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—TYMS—colon cancer	2.23e-06	0.000216	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—TYMS—colon cancer	2.23e-06	0.000215	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PPARG—colon cancer	2.21e-06	0.000213	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.14e-06	0.000206	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PPARG—colon cancer	2.12e-06	0.000204	CbGpPWpGaD
Etoposide—ABCC1—Disease—CTNNB1—colon cancer	2.11e-06	0.000203	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—EP300—colon cancer	2.09e-06	0.000202	CbGpPWpGaD
Etoposide—PTGS2—Disease—APC—colon cancer	2.08e-06	0.000201	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN1A—colon cancer	2.06e-06	0.000199	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—AKT1—colon cancer	2.05e-06	0.000197	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTGS2—colon cancer	2.04e-06	0.000197	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.01e-06	0.000194	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTGS2—colon cancer	1.97e-06	0.00019	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ABCB1—colon cancer	1.97e-06	0.00019	CbGpPWpGaD
Etoposide—ABCC1—Disease—EP300—colon cancer	1.96e-06	0.000189	CbGpPWpGaD
Etoposide—PTGS2—Disease—BRAF—colon cancer	1.96e-06	0.000189	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—TYMS—colon cancer	1.93e-06	0.000186	CbGpPWpGaD
Etoposide—ABCC1—Disease—SRC—colon cancer	1.9e-06	0.000184	CbGpPWpGaD
Etoposide—ABCC1—Disease—NRAS—colon cancer	1.83e-06	0.000177	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.83e-06	0.000176	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTGS2—colon cancer	1.73e-06	0.000167	CbGpPWpGaD
Etoposide—ABCC1—Disease—MYC—colon cancer	1.71e-06	0.000165	CbGpPWpGaD
Etoposide—ABCC1—Disease—TGFB1—colon cancer	1.7e-06	0.000164	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—EP300—colon cancer	1.7e-06	0.000164	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—TYMS—colon cancer	1.68e-06	0.000162	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PPARG—colon cancer	1.68e-06	0.000162	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.68e-06	0.000162	CbGpPWpGaD
Etoposide—ABCC1—Disease—EGFR—colon cancer	1.67e-06	0.000161	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTGS2—colon cancer	1.67e-06	0.000161	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—EP300—colon cancer	1.64e-06	0.000158	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PPARG—colon cancer	1.58e-06	0.000153	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PPARG—colon cancer	1.58e-06	0.000152	CbGpPWpGaD
Etoposide—ABCC1—Disease—KRAS—colon cancer	1.58e-06	0.000152	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CA—colon cancer	1.55e-06	0.000149	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.49e-06	0.000144	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CA—colon cancer	1.45e-06	0.00014	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—EP300—colon cancer	1.44e-06	0.000139	CbGpPWpGaD
Etoposide—PTGS2—Disease—CTNNB1—colon cancer	1.41e-06	0.000136	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.4e-06	0.000135	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—EP300—colon cancer	1.39e-06	0.000134	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1A—colon cancer	1.38e-06	0.000133	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PPARG—colon cancer	1.37e-06	0.000132	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ABCB1—colon cancer	1.37e-06	0.000132	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—TYMS—colon cancer	1.34e-06	0.00013	CbGpPWpGaD
Etoposide—ABCC1—Disease—HRAS—colon cancer	1.34e-06	0.000129	CbGpPWpGaD
Etoposide—PTGS2—Disease—EP300—colon cancer	1.31e-06	0.000127	CbGpPWpGaD
Etoposide—PTGS2—Disease—SRC—colon cancer	1.28e-06	0.000123	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—AKT1—colon cancer	1.26e-06	0.000122	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CA—colon cancer	1.26e-06	0.000121	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTGS2—colon cancer	1.25e-06	0.00012	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTGS2—colon cancer	1.24e-06	0.00012	CbGpPWpGaD
Etoposide—PTGS2—Disease—NRAS—colon cancer	1.23e-06	0.000119	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CA—colon cancer	1.21e-06	0.000117	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PPARG—colon cancer	1.19e-06	0.000115	CbGpPWpGaD
Etoposide—ABCC1—Disease—AKT1—colon cancer	1.18e-06	0.000114	CbGpPWpGaD
Etoposide—PTGS2—Disease—MYC—colon cancer	1.14e-06	0.00011	CbGpPWpGaD
Etoposide—PTGS2—Disease—TGFB1—colon cancer	1.14e-06	0.00011	CbGpPWpGaD
Etoposide—PTGS2—Disease—EGFR—colon cancer	1.12e-06	0.000108	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—EP300—colon cancer	1.1e-06	0.000106	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTGS2—colon cancer	1.08e-06	0.000104	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CA—colon cancer	1.07e-06	0.000103	CbGpPWpGaD
Etoposide—PTGS2—Disease—KRAS—colon cancer	1.06e-06	0.000102	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCB1—colon cancer	1.06e-06	0.000102	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—TYMS—colon cancer	1.04e-06	0.0001	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—EP300—colon cancer	1.04e-06	0.0001	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.03e-06	9.98e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—EP300—colon cancer	1.03e-06	9.97e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AKT1—colon cancer	1.03e-06	9.91e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CA—colon cancer	1.03e-06	9.89e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AKT1—colon cancer	9.91e-07	9.56e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CA—colon cancer	9.72e-07	9.38e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PPARG—colon cancer	9.52e-07	9.18e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTGS2—colon cancer	9.38e-07	9.05e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—HRAS—colon cancer	8.99e-07	8.68e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—EP300—colon cancer	8.95e-07	8.64e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKT1—colon cancer	8.72e-07	8.41e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKT1—colon cancer	8.38e-07	8.08e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CA—colon cancer	8.14e-07	7.85e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKT1—colon cancer	7.94e-07	7.66e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—EP300—colon cancer	7.8e-07	7.53e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CA—colon cancer	7.66e-07	7.39e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CA—colon cancer	7.65e-07	7.38e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS2—colon cancer	7.49e-07	7.22e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PPARG—colon cancer	7.35e-07	7.09e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKT1—colon cancer	6.65e-07	6.42e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CA—colon cancer	6.62e-07	6.39e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKT1—colon cancer	6.26e-07	6.04e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKT1—colon cancer	6.25e-07	6.03e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—EP300—colon cancer	6.23e-07	6.01e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS2—colon cancer	5.78e-07	5.58e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CA—colon cancer	5.77e-07	5.57e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKT1—colon cancer	5.41e-07	5.22e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—EP300—colon cancer	4.81e-07	4.64e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKT1—colon cancer	4.71e-07	4.55e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CA—colon cancer	4.61e-07	4.44e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKT1—colon cancer	3.76e-07	3.63e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CA—colon cancer	3.56e-07	3.43e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKT1—colon cancer	2.9e-07	2.8e-05	CbGpPWpGaD
